Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: implications for the treatment of human liver cancer.
about
Genetic alterations in hepatocellular carcinoma: An updateLiver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafishOIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma.MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-RasEIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinomaInteraction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.Trace metal imaging in diagnostic of hepatic metal disease.Crosstalk analysis of pathways in breast cancer using a network model based on overlapping differentially expressed genes.The Involvement of Mutual Inhibition of ERK and mTOR in PLCγ1-Mediated MMP-13 Expression in Human Osteoarthritis Chondrocytes.The AKT inhibitor MK-2206 is cytotoxic in hepatocarcinoma cells displaying hyperphosphorylated AKT-1 and synergizes with conventional chemotherapyEvaluation of uttroside B, a saponin from Solanum nigrum Linn, as a promising chemotherapeutic agent against hepatocellular carcinomaPI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells.Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.Hydrodynamic transfection for generation of novel mouse models for liver cancer research.Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapy.Differential expression of store-operated calcium- and proliferation-related genes in hepatocellular carcinoma cells following TRPC1 ion channel silencing.Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer.The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.Activation of the Akt-mTOR and MAPK pathways in dedifferentiated liposarcomas.Promising new strategies for hepatocellular carcinoma.4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice.Combination of cetuximab and rapamycin enhances the therapeutic efficacy in hepatocellular carcinoma.miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1.Lamin A/C Cardiomyopathies: Current Understanding and Novel Treatment Strategies.Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells.Inferring gene and protein interactions using PubMed citations and consensus Bayesian networks.Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation.Soft tissue sarcomas: From a morphological to a molecular biological approach.
P2860
Q28073241-004064C7-F84F-4677-9027-475481FB8B6AQ28534280-3CE7693A-72F9-4F3E-99B6-A2699C6AA4D6Q33566841-A5A4F97D-466A-4A15-BB4B-FCEB5974E0D8Q33688897-139B7DE4-1E4E-4D52-BCA9-270CDA95934EQ33845075-3DFA0DAB-1888-4CFB-96FE-AA9849070A97Q34193764-00B13E90-4319-4037-830B-F32674EF9F5FQ35058443-8CB4C9D1-B096-473B-8037-756B064C9E65Q35523618-35229EF0-A923-49DC-9E6F-2D67DDBF2D3CQ35560178-D4E418D3-0AC9-4353-85C3-D25A85721A4CQ35870241-4C3313A6-AC6E-4E10-8BFE-E3995AAD3602Q36076304-13EA373A-FFA7-4D13-83AE-51F06E147D8BQ37299276-A7D74EFE-693A-47AB-ABED-7CD795EB76E2Q37390508-EC52FBB2-2105-41DF-9A1E-FC6E4928B196Q37603821-D2704AE2-E83E-44A0-8574-5AEA1CCEBE47Q37671148-FE6CB0FD-67D1-4253-8652-17D996E5BCA0Q38183539-81ED0B79-070D-487E-B82D-90FF80D1CFE3Q38556534-EB5E9381-23BC-45E0-8800-BDCCEDE8792EQ38756607-0681169E-C504-4330-A6AB-A8674BAA14C8Q38763609-D7BABB57-FF33-4275-AA25-DDF63090088AQ38804626-96011BD5-C3C7-45F2-8000-CBA280D4622AQ38823442-377E6EEF-1420-4051-8A3D-B48403F3BE31Q38936589-24D806EB-8402-459F-978D-048D8D2224BDQ38963997-64268DCC-9E1D-4C1E-B9A8-CBF9B1CFD7FCQ39044822-23BDD06B-AC42-471C-A7CD-BAEAA9BB56C8Q39063655-3131D2A0-3B42-472F-8370-ECA36C1A3468Q39181367-6DBC5A3D-B33C-467B-9D0C-7B47E3CCBEFEQ41612184-DC8774CA-D972-42D0-89AB-472442618B11Q47140124-C17275AA-FD4D-4FBB-AB33-A2795D33DBFBQ47720139-515B2A06-A630-4035-9160-CC5FF895D8CBQ51817033-8859B475-8858-4EC0-8435-5D60FCED0DCA
P2860
Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: implications for the treatment of human liver cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Functional crosstalk between A ...... eatment of human liver cancer.
@en
type
label
Functional crosstalk between A ...... eatment of human liver cancer.
@en
prefLabel
Functional crosstalk between A ...... eatment of human liver cancer.
@en
P2093
P2860
P356
P1433
P1476
Functional crosstalk between A ...... reatment of human liver cancer
@en
P2093
Diego F Calvisi
Frank Dombrowski
Julia Armbruster
Matthias Evert
Salvatore Delogu
P2860
P304
P356
10.4161/CC.25099
P577
2013-06-06T00:00:00Z